Neurosurgery News and Research

RSS

Ziehm NaviPort interface and BrainLAB Fluoro 3D surgical navigation software improves surgical procedures

Ziehm Imaging and BrainLAB have extended their cooperation to assist surgeons in the intra-operative guidance of pedicle screw and hardware placement during surgical trauma and spinal instrumentation procedures.

27 Oct 2009

Genetic mutations cause for SIDS and SUDS

Scientists and clinicians at the Montefiore-Einstein Center for Cardiogenetics have teamed up and found that genetic mutations leading to Long QT Syndrome (LQTS) could be causing electrical malfunctioning of the heart resulting in the mysterious deaths more commonly known as Sudden Infant Death Syndrome (SIDS) and Sudden Unexplained Death Syndrome (SUDS) in people older than 12 months of age.

27 Oct 2009

New significant tool to improve the quality of care for patients with brain tumors released

While the nation is debating how best to reform healthcare, the American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) announce a new significant tool to improve the quality of care for patients who suffer from brain tumors.

27 Oct 2009

Physicians launch SUCCEED, program for breast cancer survivors

Breast cancer. A diagnosis of those two words elicits an array of emotions ranging from fear and anger, to confusion and uncertainty. To cope, women often look to family, friends and survivors for support, forming a network of people to help guide them through their diagnosis and treatment. As treatment begins, the plan seems clear.

27 Oct 2009

ImmunoCellular Therapeutics to present Phase I clinical trial data of ICT-107 vaccine in New Orleans

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, today announced that it will be presenting today, at the Annual Meeting of the Congress of Neurological Surgeons in New Orleans, Louisiana at 3:15pm central time, data from its Phase I clinical trial investigating the role that its ICT-107 vaccine may play in increasing patient survival and inhibiting tumor progression in patients with glioblastoma, the most common and most aggressive type of primary brain tumor.

26 Oct 2009

Montreal Children's Hospital inaugurates Brain Suite intraoperative MRI

The Montreal Children's Hospital inaugurates its new Brain Suite, home to the first intraoperative magnetic resonance (MRI) in a Canadian pediatric hospital and the first in Quebec.

26 Oct 2009

Enzyme Mst3b is essential for regenerating damaged axons in live animal model, say researchers

Researchers at Children's Hospital Boston report that an enzyme known as Mst3b, previously identified in their lab, is essential for regenerating damaged axons (nerve fibers) in a live animal model, in both the peripheral and central nervous systems.

26 Oct 2009

Surgery offers hope for migraine sufferers

In newly released research, 79 migraine sufferers were followed for at least five years after having undergone detection of migraine "trigger sites" and surgery. The new data finds promising outcomes for treating trigger sites surgically for migraine headaches resulting in elimination of pain for those afflicted with the condition.

26 Oct 2009

APC enzyme may be effective for treating amyotrophic lateral sclerosis

A chemical cousin of a drug currently used to treat sepsis dramatically slows the progression of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, in mice. The results offer a bit of good news in efforts to develop a therapy to stop or slow the progression of a disease that generally kills its victims within just a few years.

26 Oct 2009

IMRIS sells IMRISNV to Connecticut-based Yale-New Haven Hospital

IMRIS Inc. ("IMRIS" or the "Company") today announced the sale of IMRISNV to Connecticut-based Yale-New Haven Hospital (the "Hospital"), the primary teaching hospital for the Yale School of Medicine.

24 Oct 2009

Elekta to demonstrate stereotactic solutions at the 2009 CNS Annual Meeting

At the 2009 Congress of Neurological Surgeons (CNS) Annual Meeting, October 24-28 in New Orleans, Louisiana, Elekta will demonstrate how its line of stereotactic solutions expand treatment capabilities and bring new hope for patients presenting serious conditions.

From Elekta 24 Oct 2009

Low adiponectin levels may increase sepsis related complications

A new Canadian study has found that lower-than-normal levels of a naturally-occurring fat hormone may increase the risk of death from sepsis-an overwhelming infection of the blood which claims thousands of lives each year.

24 Oct 2009

Decrease in sales for CONMED Corporation during third quarter ended September 30, 2009

CONMED Corporation (NASDAQ: CNMD) today announced financial results for the third quarter of 2009.

22 Oct 2009

Philadelphia's Franklin Institute to exhibit Gunther von Hagens' Body Worlds 2 & The Brain

Gunther von Hagens' Body Worlds 2 & The Brain made its debut at Philadelphia's Franklin Institute on October 17, and will be one of many points of interest for visitors eager to explore the area's vast array of scientific treasures.

21 Oct 2009

Stemedica completes pre-IND meeting with the FDA concerning allogeneic mesenchymal bone marrow cells

Stemedica Cell Technologies, Inc., a world leader in stem cell research and manufacturing, announced that it completed its pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding a proposed IND (Investigative New Drug) to evaluate the safety and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.

20 Oct 2009

New mathematical model for rapid and accurate diagnoses of AHF

Researchers at St. Michael's Hospital have developed the first mathematical model in cardiology and emergency medicine to more quickly and reliably diagnose acute heart failure (AHF) in emergency room patients

19 Oct 2009

NICoE to study how brain works after sustaining combat-related injury using Elekta Neuromag

Projected to open in mid 2010, the National Intrepid Center of Excellence (NICoE) is a facility dedicated to the study and care of military personnel and veterans suffering from traumatic brain injury (TBI) and psychological health issues. Using Elekta Neuromag®, an advanced magnetoencephalography (MEG) device, NICoE plans to shed light on how the brain works after sustaining combat-related injury.

From Elekta 15 Oct 2009

More than half RCTs do not report vital information about study populations race, says study

A new study recently published online by the American Heart Journal shows that more than half of all randomized clinical trials, or RCTs, for cardiovascular disease are not reporting vital information about the study populations race or ethnicity. NYU School of Medicine researchers found that out of the 156 cardiovascular disease RCTs analyzed, only 35% of trials reported any information on race or ethnicity between 1970 and 2006. From 2000 to 2006, 46% of trials included that information.

15 Oct 2009

Riga Eastern Clinical University Hospital commences treatment with the Novalis Tx radiosurgery platform

Doctors in Latvia have begun treatments using the region's first Novalis Tx(TM) radiosurgery platform from Varian Medical Systems and BrainLAB. Two prostate cancer patients have been treated using Varian's RapidArc® radiotherapy technology at the Riga Eastern Clinical University Hospital.

14 Oct 2009

Surgeons perform groundbreaking procedure using patient's own stem cells for repairing bone deficiencies

In a first-of-its kind procedure, physicians have used stem cells taken from the fat tissue of a 14-year-old boy and combined them with growth protein and donor tissue to grow viable cheek bones in the teen.

13 Oct 2009

Neurosurgery News and Research

Ziehm NaviPort interface and BrainLAB Fluoro 3D surgical navigation software improves surgical procedures

Genetic mutations cause for SIDS and SUDS

New significant tool to improve the quality of care for patients with brain tumors released

Physicians launch SUCCEED, program for breast cancer survivors

ImmunoCellular Therapeutics to present Phase I clinical trial data of ICT-107 vaccine in New Orleans

Montreal Children's Hospital inaugurates Brain Suite intraoperative MRI

Enzyme Mst3b is essential for regenerating damaged axons in live animal model, say researchers

Surgery offers hope for migraine sufferers

APC enzyme may be effective for treating amyotrophic lateral sclerosis

IMRIS sells IMRISNV to Connecticut-based Yale-New Haven Hospital

Elekta to demonstrate stereotactic solutions at the 2009 CNS Annual Meeting

Low adiponectin levels may increase sepsis related complications

Decrease in sales for CONMED Corporation during third quarter ended September 30, 2009

Philadelphia's Franklin Institute to exhibit Gunther von Hagens' Body Worlds 2 & The Brain

Stemedica completes pre-IND meeting with the FDA concerning allogeneic mesenchymal bone marrow cells

New mathematical model for rapid and accurate diagnoses of AHF

NICoE to study how brain works after sustaining combat-related injury using Elekta Neuromag

More than half RCTs do not report vital information about study populations race, says study

Riga Eastern Clinical University Hospital commences treatment with the Novalis Tx radiosurgery platform

Surgeons perform groundbreaking procedure using patient's own stem cells for repairing bone deficiencies

Neuroscience - Third Edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News